It also exhibits anti-cancer properties by augmenting anti-tumor immunity—enhancing CD8+ T cell function—and promoting epigenetic regulation through histone acetylation and inhibition of histone deacetylases [26,27,28]. The gene discussed is CD8A; the disease is neoplasm.